YOLFTbeta
AL

Fermentalg SA

ALGAE · PA · Healthcare / Biotechnology

0.415EUR+0.01 (+1.22%)

Price History

Full chart

Market Stats

Previous Close0.41
Open0.412
Day Range0.41 – 0.4315
52-Week Range0.40 – 0.64
Volume55.94K
Market Cap54.45M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta1.04
50-Day Avg0.4623
200-Day Avg0.4784

About

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Pierre Josselin
  • Employees64
  • Headquarters4 rue RiviA re, Libourne, France, 33500, France
  • Websitehttps://www.fermentalg.com

Leadership

  • Mr. Pierre JosselinCEO & Director
  • Matthieu De BlicFinancial Director
  • Nicolas MalvertChief Operating Officer
  • Dr. Hywel Griffiths Ph.D.Chief Scientific Officer
  • Ms. Marie Jane FallourdMarketing & Products Director
  • Mr. Nico BonneSales Director
  • Ms. Emmanuelle Benitez CanoHuman Resources Director

Financials

Income Statement

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue140.00K138.00K181.00K2.31M1.66M705.00K1.27M2.31M1.89M2.21M5.65M7.65M4.06M11.50M13.38M
Growth (%)--1.43%+31.16%+1173.48%-27.81%-57.63%+80.57%+81.38%-18.23%+16.79%+156.10%+35.43%-46.94%+183.32%+16.41%
Cost of Revenue-----133.00K1.11M1.42M6.68M3.45M6.32M8.48M3.52M9.00M11.09M
Gross Profit140.00K138.00K181.00K2.31M1.66M572.00K158.00K890.00K-4.79M-1.25M-675.00K-828.00K536.00K2.50M2.29M
Gross Margin100.00%100.00%100.00%100.00%100.00%81.13%12.41%38.54%-253.65%-56.51%-11.95%-10.83%13.21%21.70%17.12%
Operating Expense1.83M3.30M2.92M6.28M7.45M6.68M7.43M8.01M5.95M9.11M8.95M9.43M11.61M11.75M11.68M
Operating Income-1.69M-3.16M-2.74M-3.98M-5.79M-6.11M-7.27M-7.12M-10.74M-10.35M-9.63M-10.26M-11.07M-9.25M-9.38M
Operating Margin-1208.57%-2289.86%-1513.81%-172.58%-347.66%-866.10%-571.25%-308.45%-569.01%-469.57%-170.52%-134.09%-272.87%-80.47%-70.11%
EBITDA-1.39M-2.28M-2.17M-3.21M-4.78M-5.46M-5.77M-5.61M-8.22M-6.16M-8.91M-7.19M-10.91M-9.99M-6.32M
EBITDA Margin-992.14%-1655.07%-1200.00%-139.09%-287.20%-774.33%-453.02%-243.14%-435.43%-279.46%-157.71%-94.00%-268.95%-86.89%-47.24%
Net Income-926.00K-2.31M-1.75M-4.05M-5.29M-7.56M-7.27M-8.09M-17.29M-6.88M-6.85M-9.87M-14.15M-12.88M-9.44M
Net Income Margin-661.43%-1670.29%-969.61%-175.66%-317.79%-1072.20%-571.01%-350.41%-916.00%-311.93%-121.30%-129.11%-348.64%-111.99%-70.51%
R&D1.58M1.49M2.62M3.31M3.10M2.57M4.52M3.51M3.64M4.87M3.73M3.85M3.49M3.68M5.24M
R&D as % of Total Revenue1128.57%1076.09%1445.86%143.82%186.06%363.97%355.22%152.14%192.90%220.63%66.05%50.39%86.10%31.97%39.15%
Interest Expense1.00K15.00K41.00K49.00K56.00K70.00K72.00K463.00K494.00K728.00K691.00K441.00K482.00K440.00K451.00K
Interest Expense % of Total Revenue0.71%10.87%22.65%2.13%3.37%9.93%5.66%20.05%26.17%33.02%12.24%5.77%11.88%3.83%3.37%

Balance Sheet

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.16M7.53M17.77M53.39M53.35M46.09M54.01M46.73M34.54M41.89M60.88M57.54M50.24M51.14M36.44M
Total Liabilities1.01M3.16M2.98M4.59M8.98M9.51M12.81M12.42M15.97M21.58M13.87M15.56M19.40M18.39M11.26M
Total Equity6.16M4.38M14.79M48.82M44.36M36.63M41.19M34.31M18.57M20.30M47.00M41.98M30.85M32.76M25.18M
Cash3.13M1.08M7.32M39.83M28.51M15.71M21.75M12.49M8.02M11.84M26.01M15.90M11.16M20.58M6.62M
Total Debt75.00K682.00K842.00K2.06M3.80M3.35M7.96M8.36M11.56M15.84M9.61M11.02M15.35M12.60M5.02M
Net Debt-3.06M-394.00K-6.47M-37.77M-24.70M-12.36M-13.79M-4.13M3.54M4.00M-16.40M-4.88M4.19M-7.98M-1.60M

Cash Flow

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.35M-279.00K-3.65M-2.41M-3.81M-3.47M-7.16M-4.11M-7.03M-8.57M-7.66M-8.24M-8.69M-531.00K-6.59M
Investing Cash Flow-1.08M-2.37M-1.78M-3.69M-9.96M-8.81M-3.18M-5.06M-1.42M-2.05M-4.75M-7.29M-1.76M-1.13M-1.75M
Financing Cash Flow75.00K596.00K11.56M38.67M1.60M376.00K16.39M-90.00K3.98M14.44M26.58M5.42M5.71M11.08M-5.62M
Capital Expenditure1.39M2.49M2.46M2.74M8.41M6.85M1.09M842.00K3.28M3.12M4.88M5.48M2.48M1.47M1.54M
Free Cash Flow-2.74M-2.77M-6.10M-5.15M-12.21M-10.32M-8.26M-4.95M-10.32M-11.70M-12.55M-13.72M-11.18M-2.00M-8.13M
FCF to OCF202.89%993.91%167.32%213.82%320.95%297.41%115.23%120.48%146.66%136.45%163.76%166.45%128.60%376.65%123.29%

Earnings

Report DateSep 11, 2017Apr 30, 2018Sep 13, 2018Apr 29, 2019Sep 16, 2019May 12, 2020Sep 16, 2020Apr 30, 2021Sep 10, 2021Nov 3, 2021Apr 22, 2022Sep 30, 2022Oct 20, 2022Apr 20, 2023Sep 13, 2023Oct 9, 2023Apr 3, 2024Sep 17, 2024Oct 3, 2024May 2, 2025Sep 23, 2025Oct 7, 2025Apr 2, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.24-0.32-0.20-0.27-0.31-0.65-0.23-0.10-0.170.00-0.05-0.130.00-0.240.000.000.000.000.00-0.08-0.040.000.00
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap54.45M
Enterprise Value53.02M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.07
Price / Book2.17
EPS-0.09
Book Value0.262
Revenue (TTM)13.38M
Gross Profit (TTM)2.29M
EBITDA-9.05M
Profit Margin-70.51%
Operating Margin-100.16%
Return on Equity-32.58%
Return on Assets-15.57%
Shares Outstanding119.79M
Shares Float61.95M
Beta1.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%